BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 11980558)

  • 1. Health care use and costs for children with attention-deficit/hyperactivity disorder: national estimates from the medical expenditure panel survey.
    Chan E; Zhan C; Homer CJ
    Arch Pediatr Adolesc Med; 2002 May; 156(5):504-11. PubMed ID: 11980558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parent-Reported Health Consequences and Relationship to Expenditures in Children with ADHD.
    deJong NA; Williams CS; Thomas KC
    Matern Child Health J; 2016 Apr; 20(4):915-24. PubMed ID: 26754346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical Expenditures Associated with Attention-Deficit/Hyperactivity Disorder Among Adults in the United States by Age, 2015-2019.
    Witrick B; Zhang D; Su D; Li Y; McCall WV; Hendricks B; Shi L
    J Gen Intern Med; 2023 Jul; 38(9):2082-2090. PubMed ID: 36781580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder.
    Leibson CL; Katusic SK; Barbaresi WJ; Ransom J; O'Brien PC
    JAMA; 2001 Jan; 285(1):60-6. PubMed ID: 11150110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National estimates of health services expenditures for children with behavioral disorders: an analysis of the medical expenditure panel survey.
    Guevara JP; Mandell DS; Rostain AL; Zhao H; Hadley TR
    Pediatrics; 2003 Dec; 112(6 Pt 1):e440. PubMed ID: 14654642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic Burden of Attention-Deficit/Hyperactivity Disorder among Pediatric Patients in the United States.
    Gupte-Singh K; Singh RR; Lawson KA
    Value Health; 2017 Apr; 20(4):602-609. PubMed ID: 28408002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder.
    Guevara J; Lozano P; Wickizer T; Mell L; Gephart H
    Pediatrics; 2001 Jul; 108(1):71-8. PubMed ID: 11433056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mothers of children diagnosed with attention-deficit/hyperactivity disorder: health conditions and medical care utilization in periods before and after birth of the child.
    Ray GT; Croen LA; Habel LA
    Med Care; 2009 Jan; 47(1):105-14. PubMed ID: 19106738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention-deficit/hyperactivity disorder in children: excess costs before and after initial diagnosis and treatment cost differences by ethnicity.
    Ray GT; Levine P; Croen LA; Bokhari FA; Hu TW; Habel LA
    Arch Pediatr Adolesc Med; 2006 Oct; 160(10):1063-9. PubMed ID: 17018466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National trends in the treatment of attention deficit hyperactivity disorder.
    Olfson M; Gameroff MJ; Marcus SC; Jensen PS
    Am J Psychiatry; 2003 Jun; 160(6):1071-7. PubMed ID: 12777264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The national cost of asthma among school-aged children in the United States.
    Sullivan PW; Ghushchyan V; Navaratnam P; Friedman HS; Kavati A; Ortiz B; Lanier B
    Ann Allergy Asthma Immunol; 2017 Sep; 119(3):246-252.e1. PubMed ID: 28890020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incremental direct expenditure of treating asthma in the United States.
    Kamble S; Bharmal M
    J Asthma; 2009 Feb; 46(1):73-80. PubMed ID: 19191142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term persistence of high health care costs in a nationally representative sample of children.
    Liptak GS; Shone LP; Auinger P; Dick AW; Ryan SA; Szilagyi PG
    Pediatrics; 2006 Oct; 118(4):e1001-9. PubMed ID: 17015496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outpatient rehabilitation utilization and medical expenses in children aged 0-7 years with ADHD: analyses of population-based national health insurance data.
    Lin JD; Chen YH; Lin LP
    Res Dev Disabil; 2013 Jul; 34(7):2127-32. PubMed ID: 23643766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economic burden of asthma in US children: estimates from the National Medical Expenditure Survey.
    Lozano P; Sullivan SD; Smith DH; Weiss KB
    J Allergy Clin Immunol; 1999 Nov; 104(5):957-63. PubMed ID: 10550739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sociodemographic and economic comparisons of children prescribed longer-acting versus short-acting stimulant medications for attention deficit hyperactivity disorder.
    Stevens J; Harman JS; Kelleher KJ
    J Behav Health Serv Res; 2005; 32(4):430-7. PubMed ID: 16215451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct medical costs of ADHD and its comorbid conditions on basis of a claims data analysis.
    Libutzki B; Ludwig S; May M; Jacobsen RH; Reif A; Hartman CA
    Eur Psychiatry; 2019 May; 58():38-44. PubMed ID: 30802682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Economic Burden of Asthma in the United States, 2008-2013.
    Nurmagambetov T; Kuwahara R; Garbe P
    Ann Am Thorac Soc; 2018 Mar; 15(3):348-356. PubMed ID: 29323930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family structure and the treatment of childhood asthma.
    Chen AY; Escarce JJ
    Med Care; 2008 Feb; 46(2):174-84. PubMed ID: 18219246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of obesity on health service utilization and costs in childhood.
    Trasande L; Chatterjee S
    Obesity (Silver Spring); 2009 Sep; 17(9):1749-54. PubMed ID: 19300433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.